SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-18-009697
Filing Date
2018-07-26
Accepted
2018-07-26 16:10:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0718alphacap_eloxxpharm.htm SC 13G 41818
  Complete submission text file 0001213900-18-009697.txt   43678
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-56243 | Film No.: 18971865
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999
Business Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999 0114232376363
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000
Type: SC 13G